A multinational, multicenter, open-label, controlled, randomised, parallel group study to evaluate the efficacy and safety of EMD 121974 and gemcitabine or gemcitabine alone in patients with advanced, unresectable pancreatic cancer
2019 ◽
Vol 182
(4)
◽
pp. 869-879
◽
Keyword(s):
2013 ◽
Vol 131
(2)
◽
pp. AB101
2017 ◽
Vol 8
(2)
◽
Keyword(s):
2000 ◽
Vol 26
(2)
◽
pp. 203-210
◽
Keyword(s):
2021 ◽
Vol 147
(2)
◽
pp. AB59
Keyword(s):